Competence Centre TEDD
Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement).
REGISTRATION OPEN: 7 June 2023 TEDD Visit: University of Zurich Department of Pathology and Molecular Pathology
TEDD Partners have an opportunity to visit University of Zurich Department of Pathology and Molecular Pathology.
Deadline for registration is 31st May 2023.
Confirmed Speakers
Prof Javad Nazarian, University Childrens‘ Hospital Zurich, Oncology Department
From biopsy to cure: a challenge for precision oncology
Bianca Fischli , ZHAW/TEDD (Team of Prof. Michael Raghunath)
Vascular pattern making using sound induced morphogenesis – experience with the first commercial CymatiX instrument
Prof Benjamin Gantenbein, University of Bern, Medical Faculty, Department for BioMedical Research
What regeneration in orthopaedics might bring to an increasingly elderly society
Dr Arno Amann, Department of Haematology and Oncology, Medical University of Innsbruck
title tbc
Dr Markus Mühlemann, Kugelmeiers
The role of standardized spheroids in pancreatic islet transplantation
Dr Deana Mohr, MUVON Therapeutics
MUVON from bench to bedside
EXHIBITION CALL TEDD ANNUAL MEETING
The exhibition call is open in. TEDD Partners Exhibit for free and have priority.
Please contact Kasia Kopanska at info.tedd@zhaw.ch to book your booth.
If you are not TEDD Parter and would like to exhibit please Join TEDD as Partner
NEW TEDD Partner Sino Biological
We welcome a new TEDD Partner!
Sino Biological is dedicated to providing the scientific community with high-quality recombinant protein and antibody reagents to promote life science research and drug discovery.
With the largest validated recombinant protein bank (6000+), a broad range of antigens are covered, including viral proteins, cytokines and growth factors, immune checkpoints, antigens for CAR-T cell therapy, Fc receptors, biomarker proteins, etc, as well as a comprehensive collection of high quality mono- and polyclonal antibodies.
Based on our rich experiences and expertise, several robust recombinant protein expression platforms and antibody discovery methods have been established for customized contracted research projects.
TEDD Partnership Fee 2023
Yearly TEDD Partnership fee 2023 is CHF 500.
TEDD Partnership conditions:
- Two people from TEDD Partner organization can attend TEDD events free of charge. Subsequent people from this organization will receive a 50% discount for that event.
- TEDD Partnership period is from January to December of the given year.
- TEDD Partnership extends for the following year unless cancelled.
- TEDD Partner can cancel partnership latest on 30 November of the current year effective next year by sending us an email on info.tedd@zhaw.ch.
TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.
This might also interest you
Partnership
Who are our Partners? What are the benefits of joining our network? How to become a Partner of CC TEDD?
About
Partnership
Team
Learn more about vision, goals, competencies and history of CC TEDD.
Who are our Partners? What are the benefits of joining our network? How to become a Partner of CC TEDD?
Meet the team and board of the Competence Centre.